Medicine and Dentistry
Bone Scintigraphy
15%
Breast Cancer
7%
Cancer Cell
13%
Carcinoid
8%
Clinical Management
7%
Colorectal Cancer
17%
Colorectal Carcinoma
13%
Computed Tomography Studies
7%
Computer Assisted Tomography
52%
Deoxyglucose
13%
Diagnosis
26%
Disease
25%
False Negative Result
7%
Fluorine-18
23%
Fluorodeoxyglucose
16%
Fluorodeoxyglucose F 18
43%
Gallium 68
20%
Image Quality
7%
Liver Metastasis
7%
Low Drug Dose
9%
Lymph Node
8%
Malignant Neoplasm
9%
Metastatic Carcinoma
13%
Neck
19%
Neoplasm
22%
Patient Care
7%
Pelvis
9%
Pentetic Acid
7%
Positron Emission Tomography
38%
Positron Emission Tomography
28%
Positron Emission Tomography-Computed Tomography
100%
Progression Free Survival
9%
Prostate Cancer
13%
Pulmonary Embolism
6%
Radiation Therapy
10%
Radioisotope
9%
Recurrent Disease
14%
Rituximab
14%
Scintiscanning
8%
Single-Photon Emission Computed Tomography
8%
Solid Malignant Neoplasm
6%
Squamous Cell
13%
Standardized Uptake Value
9%
Survival Rate
7%
Symptom
8%
Technetium
10%
Technetium-99
11%
Traumatic Brain Injury
10%
Treatment Planning
8%
Treatment Response
9%
Keyphrases
18F-FDG PET-CT
21%
18F-fluorodeoxyglucose (18F-FDG)
9%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
13%
Anatomic
9%
Autoantibodies
15%
Bone Scan
34%
Brain Imaging
9%
Colorectal Carcinoma
13%
Computed Tomography
25%
Computerized Tomography
11%
CT Findings
9%
CT Studies
12%
Detection Rate
10%
Disease Diagnosis
13%
FDG PET-CT
18%
FDG Uptake
15%
Fluorine-18
13%
Fluorine-18 Fluorodeoxyglucose
8%
Fluorodeoxyglucose
18%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
12%
Head-and-neck
13%
Head-and-neck Cancer
13%
IgA Nephropathy (IgAN)
13%
Lymph Node Location
9%
Lymphoma
15%
Medical Center
8%
Obsessive-compulsive Disorder
13%
Older Men
12%
Pathologic
11%
Patient Assessment
15%
Patient Management
10%
PET-computed Tomography
14%
Pitfalls in Interpretation
13%
Positron Emission Tomography
15%
Positron Emission Tomography-computed Tomography (PET-CT)
92%
Progression-free Survival
9%
Radionuclide Imaging
8%
Response to Treatment
9%
Rituximab
14%
Single-photon Emission Computed Tomography (SPECT)
24%
Spleen
11%
Squamous Cell Cancer
13%
Standardized Uptake Value
8%
Stress Fracture
13%
SUVmax
15%
Tc-99m DTPA
13%
Technetium
11%
Technetium-99m
22%
Therapeutic Approaches
8%
Tumor
12%